{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:52:37Z","timestamp":1788385957848,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10067-022-06443-1","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:18:26Z","timestamp":1669310306000},"page":"1635-1643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["AIM2 and NLRC4-driven inflammasome activation in adult-onset Still\u2019s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole"],"prefix":"10.1007","volume":"42","author":[{"given":"Mengyuan","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3471-1663","authenticated-orcid":false,"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"6443_CR1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/art.41635","volume":"73","author":"M Wang","year":"2021","unstructured":"Wang M, Liu M, Jia J, Shi H, Teng J, Liu H et al (2021) Association of the leukocyte immunoglobulin-like receptor A3 gene with neutrophil activation and disease susceptibility in adult-onset Still\u2019s disease. Arthritis Rheumatol 73:1033\u20131043. https:\/\/doi.org\/10.1002\/art.41635","journal-title":"Arthritis Rheumatol"},{"key":"6443_CR2","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.3390\/ijms222413320","volume":"22","author":"B Maranini","year":"2021","unstructured":"Maranini B, Ciancio G, Govoni M (2021) Adult-onset Still\u2019s disease: novel biomarkers of specific subsets, disease activity, and relapsing forms. Int J Mol Sci 22:13320. https:\/\/doi.org\/10.3390\/ijms222413320","journal-title":"Int J Mol Sci"},{"key":"6443_CR3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.semarthrit.2021.06.004","volume":"51","author":"P Efthimiou","year":"2021","unstructured":"Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P (2021) Adult-onset Still\u2019s disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum 51:858\u2013874. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.004","journal-title":"Semin Arthritis Rheum"},{"key":"6443_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/1744666X.2017.1332994","volume":"13","author":"DH Yoo","year":"2017","unstructured":"Yoo DH (2017) Treatment of adult-onset still\u2019s disease: up to date. Expert Rev Clin Immunol 13:849\u2013866. https:\/\/doi.org\/10.1080\/1744666X.2017.1332994","journal-title":"Expert Rev Clin Immunol"},{"key":"6443_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14:603\u2013618. https:\/\/doi.org\/10.1038\/s41584-018-0081-x","journal-title":"Nat Rev Rheumatol"},{"key":"6443_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397\u2013411. https:\/\/doi.org\/10.1038\/nri3452","journal-title":"Nat Rev Immunol"},{"key":"6443_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.tcb.2021.06.010","volume":"31","author":"A Pandey","year":"2021","unstructured":"Pandey A, Shen C, Feng S, Man SM (2021) Cell biology of inflammasome activation. Trends Cell Biol 31:924\u2013939. https:\/\/doi.org\/10.1016\/j.tcb.2021.06.010","journal-title":"Trends Cell Biol"},{"key":"6443_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41577-021-00588-x","volume":"21","author":"SM Vora","year":"2021","unstructured":"Vora SM, Lieberman J, Wu H (2021) Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 21:694\u2013703. https:\/\/doi.org\/10.1038\/s41577-021-00588-x","journal-title":"Nat Rev Immunol"},{"key":"6443_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/jnci\/82.1.54","volume":"82","author":"EC Kohn","year":"1990","unstructured":"Kohn EC, Liotta LA (1990) L651582: a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 82:54\u201360. https:\/\/doi.org\/10.1093\/jnci\/82.1.54","journal-title":"J Natl Cancer Inst"},{"key":"6443_CR10","first-page":"3208","volume":"52","author":"EC Kohn","year":"1992","unstructured":"Kohn EC, Sandeen MA, Liotta LA (1992) In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res 52:3208\u20133212","journal-title":"Cancer Res"},{"key":"6443_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1124\/jpet.107.131888","volume":"325","author":"L Guo","year":"2008","unstructured":"Guo L, Ye C, Chen W, Ye H, Zheng R, Li J et al (2008) Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumorostatic agent. J Pharmacol Exp Ther 325:10\u201316. https:\/\/doi.org\/10.1124\/jpet.107.131888","journal-title":"J Pharmacol Exp Ther"},{"key":"6443_CR12","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1111\/bph.13138","volume":"172","author":"L Zhu","year":"2015","unstructured":"Zhu L, Li J, Guo L, Yu X, Wu D, Luo L et al (2015) Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis. Br J Pharmacol 172:3446\u20133459. https:\/\/doi.org\/10.1111\/bph.13138","journal-title":"Br J Pharmacol"},{"key":"6443_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.intimp.2017.01.015","volume":"45","author":"X Du","year":"2017","unstructured":"Du X, Chen W, Wang Y, Chen C, Guo L, Ju R et al (2017) Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-\u03baB activation. Int Immunopharmacol 45:16\u201325. https:\/\/doi.org\/10.1016\/j.intimp.2017.01.015","journal-title":"Int Immunopharmacol"},{"key":"6443_CR14","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3892\/etm.2020.8889","volume":"20","author":"S Lu","year":"2020","unstructured":"Lu S, Duan M, Guo Z, Zhou Y, Wu D, Zhang X et al (2020) Carboxyamidotriazole exerts anti-inflammatory activity in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-\u03baB and MAPKs pathways. Exp Ther Med 20:1455\u20131466. https:\/\/doi.org\/10.3892\/etm.2020.8889","journal-title":"Exp Ther Med"},{"key":"6443_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3881\/j.issn.1000-503X.2016.01.009","volume":"38","author":"L Zhu","year":"2016","unstructured":"Zhu L, Li J, Guo L, Yu XL, Wu DW, Chen W et al (2016) Therapeutic effect of carboxyamidotriazole on adjuvant arthritis in rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 38:49\u201354. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.2016.01.009","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"6443_CR16","doi-asserted-by":"publisher","first-page":"6502373","DOI":"10.1155\/2016\/6502373","volume":"2016","author":"R Gopalarathinam","year":"2016","unstructured":"Gopalarathinam R, Orlowsky E, Kesavalu R, Yelaminchili S (2016) Adult onset Still\u2019s disease: a review on diagnostic workup and treatment options. Case Rep Rheumatol 2016:6502373. https:\/\/doi.org\/10.1155\/2016\/6502373","journal-title":"Case Rep Rheumatol"},{"key":"6443_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P (2014) Adult-onset Still\u2019s disease. Autoimmun Rev 13:708\u2013722. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.058","journal-title":"Autoimmun Rev"},{"key":"6443_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, D\u00e9cary F, Salusinsky-Sternbach M et al (1991) Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118\u2013136","journal-title":"Medicine (Baltimore)"},{"key":"6443_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot5080","author":"J Weischenfeldt","year":"2008","unstructured":"Weischenfeldt J, Porse B (2008) Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. https:\/\/doi.org\/10.1101\/pdb.prot5080","journal-title":"CSH Protoc"},{"key":"6443_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cell.2018.02.055","volume":"173","author":"R Karki","year":"2018","unstructured":"Karki R, Lee E, Place D, Samir P, Mavuluri J, Sharma BR et al (2018) IRF8 regulates transcription of Naips for NLRC4 Inflammasome Activation. Cell 173:920\u2013933. https:\/\/doi.org\/10.1016\/j.cell.2018.02.055","journal-title":"Cell"},{"key":"6443_CR21","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T et al (2018) OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci U S A 115:E1530\u2013E1539. https:\/\/doi.org\/10.1073\/pnas.1716095115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6443_CR22","doi-asserted-by":"publisher","first-page":"603389","DOI":"10.3389\/fimmu.2020.603389","volume":"11","author":"J Meng","year":"2021","unstructured":"Meng J, Ma Y, Jia J, Wang M, Teng J, Shi H et al (2021) Cytokine storm in coronavirus disease 2019 and adult-onset Still\u2019s disease: similarities and differences. Front Immunol 11:603389. https:\/\/doi.org\/10.3389\/fimmu.2020.603389","journal-title":"Front Immunol"},{"key":"6443_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","volume":"37","author":"I K\u00f6tter","year":"2007","unstructured":"K\u00f6tter I, Wacker A, Koch S, Henes J, Richter C, Engel A et al (2007) Anakinra in patients with treatment-resistant adult-onset Still\u2019s disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 37:189\u2013197. https:\/\/doi.org\/10.1016\/j.semarthrit.2007.04.002","journal-title":"Semin Arthritis Rheum"},{"key":"6443_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/14737159.2019.1615449","volume":"19","author":"JY Jung","year":"2019","unstructured":"Jung JY, Suh CH, Kim HA (2019) The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still\u2019s disease. Expert Rev Mol Diagn 19:459\u2013468. https:\/\/doi.org\/10.1080\/14737159.2019.1615449","journal-title":"Expert Rev Mol Diagn"},{"key":"6443_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13238-013-2128-8","volume":"4","author":"S Chen","year":"2013","unstructured":"Chen S, Sun B (2013) Negative regulation of NLRP3 inflammasome signaling. Protein Cell 4:251\u2013258. https:\/\/doi.org\/10.1007\/s13238-013-2128-8","journal-title":"Protein Cell"},{"key":"6443_CR26","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1093\/rheumatology\/keab485","volume":"60","author":"Y Ma","year":"2021","unstructured":"Ma Y, Meng J, Jia J, Wang M, Teng J, Zhu D et al (2021) Current and emerging biological therapy in adult-onset Still\u2019s disease. Rheumatology (Oxford) 60:3986\u20134000. https:\/\/doi.org\/10.1093\/rheumatology\/keab485","journal-title":"Rheumatology (Oxford)"},{"key":"6443_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-018-1800-z","volume":"21","author":"Q Hu","year":"2019","unstructured":"Hu Q, Shi H, Zeng T, Liu H, Su Y, Cheng X et al (2019) Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still\u2019s disease. Arthritis Res Ther 21:9. https:\/\/doi.org\/10.1186\/s13075-018-1800-z","journal-title":"Arthritis Res Ther"},{"key":"6443_CR28","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3389\/fphar.2018.01074","volume":"9","author":"P Galozzi","year":"2018","unstructured":"Galozzi P, Baggio C, Bindoli S, Oliviero F, Sfriso P (2018) Development and role in therapy of Canakinumab in adult-onset Still\u2019s disease. Front Pharmacol 9:1074. https:\/\/doi.org\/10.3389\/fphar.2018.01074","journal-title":"Front Pharmacol"},{"key":"6443_CR29","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3899\/jrheum.161354","volume":"44","author":"CW Hsieh","year":"2017","unstructured":"Hsieh CW, Chen YM, Lin CC, Tang KT, Chen HH, Hung WT et al (2017) Elevated expression of the NLRP3 inflammasome and its correlation with disease activity in adult-onset Still disease. J Rheumatol 44:1142\u20131150. https:\/\/doi.org\/10.3899\/jrheum.161354","journal-title":"J Rheumatol"},{"key":"6443_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/ard.59.6.490c","volume":"59","author":"FJ Escudero","year":"2000","unstructured":"Escudero FJ, Len O, Falc\u00f3 V, de Sevilla TF, Sellas A (2000) Rubella infection in adult onset Still\u2019s disease. Ann Rheum Dis 59:493. https:\/\/doi.org\/10.1136\/ard.59.6.490c","journal-title":"Ann Rheum Dis"},{"key":"6443_CR31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fimmu.2019.00898","volume":"10","author":"J Jia","year":"2019","unstructured":"Jia J, Shi H, Liu M, Liu T, Gu J, Wan L et al (2019) Cytomegalovirus infection may trigger adult-onset Still\u2019s disease onset or relapses. Front Immunol 10:898. https:\/\/doi.org\/10.3389\/fimmu.2019.00898","journal-title":"Front Immunol"},{"key":"6443_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/s0002-9343(02)01238-x","volume":"113","author":"M Daibata","year":"2002","unstructured":"Daibata M, Taguchi H (2002) Human herpesvirus 6 and adult-onset Still\u2019s disease. Am J Med 113:532. https:\/\/doi.org\/10.1016\/s0002-9343(02)01238-x","journal-title":"Am J Med"},{"key":"6443_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/imr.12903","volume":"29","author":"P Kumari","year":"2020","unstructured":"Kumari P, Russo AJ, Shivcharan S, Rathinam VA (2020) AIM2 in health and disease: inflammasome and beyond. Immunol Rev 29:83\u201395. https:\/\/doi.org\/10.1111\/imr.12903","journal-title":"Immunol Rev"},{"key":"6443_CR34","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/ijms22031048","volume":"22","author":"B Sundaram","year":"2021","unstructured":"Sundaram B, Kanneganti TD (2021) Advances in understanding activation and function of the NLRC4 inflammasome. Int J Mol Sci 22:1048. https:\/\/doi.org\/10.3390\/ijms22031048","journal-title":"Int J Mol Sci"},{"key":"6443_CR35","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y et al (2014) An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 46:1140\u20131146. https:\/\/doi.org\/10.1038\/ng.3089","journal-title":"Nat Genet"},{"key":"6443_CR36","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","volume":"32","author":"HA Kim","year":"2012","unstructured":"Kim HA, Sung JM, Suh CH (2012) Therapeutic responses and prognosis in adult-onset Still\u2019s disease. Rheumatol Int 32:1291\u20131298. https:\/\/doi.org\/10.1007\/s00296-011-1801-6","journal-title":"Rheumatol Int"},{"key":"6443_CR37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/jcm10040733","volume":"10","author":"S Tomaras","year":"2021","unstructured":"Tomaras S, Goetzke CC, Kallinich T, Feist E (2021) Adult-onset Still\u2019s disease: clinical aspects and therapeutic approach. J Clin Med 10:733. https:\/\/doi.org\/10.3390\/jcm10040733","journal-title":"J Clin Med"},{"key":"6443_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.canlet.2015.10.025","volume":"370","author":"R Ju","year":"2016","unstructured":"Ju R, Guo L, Li J, Zhu L, Yu X, Chen C et al (2016) Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition. Cancer Lett 370:232\u2013241. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.025","journal-title":"Cancer Lett"},{"key":"6443_CR39","first-page":"569","volume":"56","author":"EC Kohn","year":"1996","unstructured":"Kohn EC, Reed E, Sarosy G, Christian M, Link CJ, Cole K et al (1996) Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res 56:569\u2013573","journal-title":"Cancer Res"},{"key":"6443_CR40","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2005.44.150","volume":"23","author":"WM Stadler","year":"2005","unstructured":"Stadler WM, Rosner G, Small E, Hollis D, Rini B, Zaentz SD et al (2005) Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma\u2014CALGB 69901. J Clin Oncol 23:3726\u20133732. https:\/\/doi.org\/10.1200\/JCO.2005.44.150","journal-title":"J Clin Oncol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06443-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T07:04:56Z","timestamp":1684739096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06443-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6443"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06443-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences approved this project (002\u20132018), and each participant\u2019s written consent was obtained according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}